Literature DB >> 26834014

PGC-1α regulates the cell cycle through ATP and ROS in CH1 cells.

Xu-feng Fu1,2, Kun Yao1, Xing Du1, Yan Li1, Xiu-yu Yang1, Min Yu1, Mei-zhang Li1, Qing-hua Cui1.   

Abstract

Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) is a transcriptional co-activator involved in mitochondrial biogenesis, respiratory capacity, and oxidative phosphorylation (OXPHOS). PGC-1α plays an important role in cellular metabolism and is associated with tumorigenesis, suggesting an involvement in cell cycle progression. However, the underlying mechanisms mediating its involvement in these processes remain unclear. To elucidate the signaling pathways involved in PGC-1α function, we established a cell line, CH1 PGC-1α, which stably overexpresses PGC-1α. Using this cell line, we found that over-expression of PGC-1α stimulated extra adenosine triphosphate (ATP) and reduced reactive oxygen species (ROS) production. These effects were accompanied by up-regulation of the cell cycle checkpoint regulators CyclinD1 and CyclinB1. We hypothesized that ATP and ROS function as cellular signals to regulate cyclins and control cell cycle progression. Indeed, we found that reduction of ATP levels down-regulated CyclinD1 but not CyclinB1, whereas elevation of ROS levels down-regulated CyclinB1 but not CyclinD1. Furthermore, both low ATP levels and elevated ROS levels inhibited cell growth, but PGC-1α was maintained at a constant level. Together, these results demonstrate that PGC-1α regulates cell cycle progression through modulation of CyclinD1 and CyclinB1 by ATP and ROS. These findings suggest that PGC-1α potentially coordinates energy metabolism together with the cell cycle.

Entities:  

Keywords:  Cell cycle; CyclinB1; CyclinD1; Mitochondria; Oxidative phosphorylation (OXPHOS); Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α)

Mesh:

Substances:

Year:  2016        PMID: 26834014      PMCID: PMC4757583          DOI: 10.1631/jzus.B1500158

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  35 in total

1.  Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling.

Authors:  Zachary A Wood; Leslie B Poole; P Andrew Karplus
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

2.  Postmortem Alzheimer's Disease Hippocampi Show Oxidative Phosphorylation Gene Expression Opposite that of Isolated Pyramidal Neurons.

Authors:  Ann C Rice; Amy C Ladd; James P Bennett
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 3.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

4.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

Authors:  Z Wu; P Puigserver; U Andersson; C Zhang; G Adelmant; V Mootha; A Troy; S Cinti; B Lowell; R C Scarpulla; B M Spiegelman
Journal:  Cell       Date:  1999-07-09       Impact factor: 41.582

6.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

Authors:  J J Lehman; P M Barger; A Kovacs; J E Saffitz; D M Medeiros; D P Kelly
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

7.  Effect of lipopolysaccharide on the hemocyte apoptosis of Eriocheir sinensis.

Authors:  Hai-sheng Xu; Sun-jian Lyu; Jie-hao Xu; Bin-jie Lu; Jing Zhao; Song Li; Yi-qun Li; Yu-yin Chen
Journal:  J Zhejiang Univ Sci B       Date:  2015-12       Impact factor: 3.066

Review 8.  Brown adipose tissue. More than an effector of thermogenesis?

Authors:  B Cannon; J Houstek; J Nedergaard
Journal:  Ann N Y Acad Sci       Date:  1998-09-29       Impact factor: 5.691

9.  Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo.

Authors:  Aline Meirhaeghe; Vivion Crowley; Carol Lenaghan; Christopher Lelliott; Kath Green; Abigail Stewart; Kevin Hart; Sven Schinner; Jaswinder K Sethi; Giles Yeo; Martin D Brand; Ron N Cortright; Stephen O'Rahilly; Carl Montague; Antonio J Vidal-Puig
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

Review 10.  Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities.

Authors:  Marni J Falk; Lishuang Shen; Michael Gonzalez; Jeremy Leipzig; Marie T Lott; Alphons P M Stassen; Maria Angela Diroma; Daniel Navarro-Gomez; Philip Yeske; Renkui Bai; Richard G Boles; Virginia Brilhante; David Ralph; Jeana T DaRe; Robert Shelton; Sharon F Terry; Zhe Zhang; William C Copeland; Mannis van Oven; Holger Prokisch; Douglas C Wallace; Marcella Attimonelli; Danuta Krotoski; Stephan Zuchner; Xiaowu Gai
Journal:  Mol Genet Metab       Date:  2014-12-04       Impact factor: 4.797

View more
  9 in total

1.  Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells.

Authors:  Ines Bruns; Benedikt Sauer; Michael C Burger; Jule Eriksson; Ute Hofmann; Yannick Braun; Patrick N Harter; Anna-Luisa Luger; Michael W Ronellenfitsch; Joachim P Steinbach; Johannes Rieger
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

Review 2.  Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise.

Authors:  Anand Thirupathi; Claudio Teodoro de Souza
Journal:  J Physiol Biochem       Date:  2017-07-14       Impact factor: 4.158

3.  Bcl-2 delays cell cycle through mitochondrial ATP and ROS.

Authors:  Xing Du; Xufeng Fu; Kun Yao; Zhenwei Lan; Hui Xu; Qinghua Cui; Elizabeth Yang
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

4.  GTPase-activating protein Elmod2 is essential for meiotic progression in mouse oocytes.

Authors:  Chun-Xiang Zhou; Li-Ya Shi; Rui-Chao Li; Ya-Hong Liu; Bo-Qun Xu; Jin-Wei Liu; Bo Yuan; Zhi-Xia Yang; Xiao-Yan Ying; Dong Zhang
Journal:  Cell Cycle       Date:  2017-03-21       Impact factor: 4.534

5.  A proteomic analysis of Bcl-2 regulation of cell cycle arrest: insight into the mechanisms.

Authors:  Xing DU; Jingjing Xiao; Xufeng Fu; Bo Xu; Hang Han; Yin Wang; Xiuying Pei
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

6.  Vitrification of Rhesus Macaque Mesenchymal Stem Cells and the Effects on Global Gene Expression.

Authors:  Xufeng Fu; Yaping Yan; Shanshan Li; Junfeng Wang; Bin Jiang; Hong Wang; Yanchao Duan; Tao Tan; Fei Gao; Desheng Gong; Yuyu Niu; Weizhi Ji; Bingrong Zheng; Wei Si
Journal:  Stem Cells Int       Date:  2017-10-24       Impact factor: 5.443

7.  Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response.

Authors:  George S Scaria; Betsy T Kren; Mark A Klein
Journal:  Pharmaceuticals (Basel)       Date:  2020-02-05

8.  Photobiomodulation promotes repair following spinal cord injury by restoring neuronal mitochondrial bioenergetics via AMPK/PGC-1α/TFAM pathway.

Authors:  Zhijie Zhu; Xuankang Wang; Zhiwen Song; Xiaoshuang Zuo; Yangguang Ma; Zhihao Zhang; Cheng Ju; Zhuowen Liang; Kun Li; Xueyu Hu; Zhe Wang
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

9.  A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.

Authors:  Sotiris Kyriakou; William Cheung; Theodora Mantso; Melina Mitsiogianni; Ioannis Anestopoulos; Stephany Veuger; Dimitris T Trafalis; Rodrigo Franco; Aglaia Pappa; David Tetard; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2021-02-23       Impact factor: 3.850

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.